These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 18677204)
1. Evaluation of 99mTcN-15C5 as a new myocardial perfusion imaging agent in normal dogs and canines with coronary stenosis. Fang W; Liu Y; Zhu L; Kim YS; Liu S; He ZX Nucl Med Commun; 2008 Sep; 29(9):775-81. PubMed ID: 18677204 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of (99) (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99) (m)Tc-sestamibi. Bu L; Li R; Jin Z; Wen X; Liu S; Yang B; Shen B; Chen X Mol Imaging Biol; 2011 Feb; 13(1):121-7. PubMed ID: 20458635 [TBL] [Abstract][Full Text] [Related]
3. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics. Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310 [TBL] [Abstract][Full Text] [Related]
4. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging. He Z; Hsieh WY; Kim YS; Liu S Nucl Med Biol; 2006 Nov; 33(8):1045-53. PubMed ID: 17127179 [TBL] [Abstract][Full Text] [Related]
6. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487 [TBL] [Abstract][Full Text] [Related]
7. Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses. Hatada K; Ruiz M; Riou LM; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK J Nucl Cardiol; 2006 Nov; 13(6):779-90. PubMed ID: 17174809 [TBL] [Abstract][Full Text] [Related]
8. Kinetic characterization of a novel cationic (99m)Tc(I)-tricarbonyl complex, (99m)Tc-15C5-PNP, for myocardial perfusion imaging. Liu Z; Chen L; Liu S; Barber C; Stevenson GD; Furenlid LR; Barrett HH; Woolfenden JM J Nucl Cardiol; 2010 Oct; 17(5):858-67. PubMed ID: 20669059 [TBL] [Abstract][Full Text] [Related]
9. Experimental study of [99mTc(PNP5) (DBODC)]+ as a new myocardial perfusion imaging agent. Zhang WC; Fang W; Li B; Wang XB; He ZX Cardiology; 2009; 112(2):89-97. PubMed ID: 18583906 [TBL] [Abstract][Full Text] [Related]
10. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging. Wu JC; Yun JJ; Heller EN; Dione DP; DeMan P; Liu YH; Zaret BL; Wackers FJ; Sinusas AJ J Nucl Med; 1998 Mar; 39(3):417-25. PubMed ID: 9529285 [TBL] [Abstract][Full Text] [Related]
11. New Fang W; Liu S Curr Radiopharm; 2019; 12(3):171-186. PubMed ID: 30727939 [TBL] [Abstract][Full Text] [Related]
12. Correlation between myocardial uptake of technetium-99m-sestamibi and pressure-derived myocardial fractional flow reserve. Morishima T; Chikamori T; Hatano T; Tanaka N; Takazawa K; Yamashina A J Cardiol; 2004 Apr; 43(4):155-63. PubMed ID: 15125379 [TBL] [Abstract][Full Text] [Related]
13. [Semiquantification of pulmonary and hepatic uptake of technetium-99m-tetrofosmin in myocardial perfusion imaging using multiple regions of interest. Multifactorial correlation]. Zafirakis A; Koutsikos I; Velidaki A; Mablekos G Hell J Nucl Med; 2007; 10(2):129-37. PubMed ID: 17684594 [TBL] [Abstract][Full Text] [Related]
14. Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging. Goethals LR; Santos I; Caveliers V; Paulo A; De Geeter F; Lurdes PG; Fernandes C; Lahoutte T Contrast Media Mol Imaging; 2011; 6(4):178-88. PubMed ID: 21861278 [TBL] [Abstract][Full Text] [Related]
15. 99mTc-N-DBODC5: a novel myocardial perfusion imaging agent for diagnosis of coronary artery disease, a review. Takeda T; Wu J; Lwin TT Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):161-6. PubMed ID: 18221083 [TBL] [Abstract][Full Text] [Related]
16. Impact of bidentate chelators on lipophilicity, stability, and biodistribution characteristics of cationic 99mTc-nitrido complexes. Kim YS; He Z; Hsieh WY; Liu S Bioconjug Chem; 2007; 18(3):929-36. PubMed ID: 17352455 [TBL] [Abstract][Full Text] [Related]
17. Myocardial tomography with technetium-99m-tetrofosmin during intravenous infusion of adenosine triphosphate. Takeishi Y; Takahashi N; Fujiwara S; Atsumi H; Takahashi K; Tomoike H J Nucl Med; 1998 Apr; 39(4):582-6. PubMed ID: 9544660 [TBL] [Abstract][Full Text] [Related]
19. 99mTcN complexes of tert-butyl dithiocarbamate and methoxyisobutyl dithiocarbamate as myocardial and brain imaging agents. Mathur A; Mallia MB; Subramanian S; Banerjee S; Kothari K; Dhotare B; Sarma HD; Venkatesh M Nucl Med Commun; 2005 Nov; 26(11):1013-9. PubMed ID: 16208180 [TBL] [Abstract][Full Text] [Related]
20. Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: comparison with 99mTc-tetrofosmin. Madar I; Ravert H; Dipaula A; Du Y; Dannals RF; Becker L J Nucl Med; 2007 Jun; 48(6):1021-30. PubMed ID: 17504876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]